Top Page
Drdgold
(NYSE:DRD)
Drdgold (DRD) vs. SPDR S&P 500 ETF (SPY)
Drdgold Business Overview & Revenue Model
Drdgold Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.88B | 7.88B | 6.24B | 5.50B | 5.12B | 5.27B |
| Gross Profit | 3.10B | 3.13B | 1.81B | 1.59B | 1.38B | 1.88B |
| EBITDA | 3.51B | 3.38B | 1.86B | 1.96B | 1.78B | 2.07B |
| Net Income | 2.24B | 2.24B | 1.33B | 1.28B | 1.12B | 1.44B |
Balance Sheet | ||||||
| Total Assets | 12.25B | 12.25B | 9.45B | 8.15B | 7.08B | 6.35B |
| Cash, Cash Equivalents and Short-Term Investments | 1.31B | 1.31B | 521.50M | 2.46B | 2.51B | 2.18B |
| Total Debt | 17.40M | 17.40M | 29.20M | 39.70M | 52.30M | 54.80M |
| Total Liabilities | 3.36B | 3.36B | 2.56B | 1.88B | 1.64B | 1.53B |
| Stockholders Equity | 8.88B | 8.88B | 6.89B | 6.27B | 5.44B | 4.82B |
Cash Flow | ||||||
| Free Cash Flow | 1.26B | 1.26B | -1.14B | 510.40M | 913.70M | 1.18B |
| Operating Cash Flow | 3.51B | 3.51B | 1.85B | 1.66B | 1.50B | 1.57B |
| Investing Cash Flow | -2.28B | -2.28B | -3.04B | -1.19B | -626.20M | -446.60M |
| Financing Cash Flow | -443.10M | -443.10M | -750.70M | -532.20M | -533.00M | -653.50M |
Drdgold Technical Analysis
Drdgold Risk Analysis
Drdgold Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | $10.60B | 12.96 | 32.05% | 1.26% | 29.08% | 72.12% | |
| ― | $35.03B | 18.24 | 35.09% | 2.02% | 49.62% | 195.39% | |
| ― | $542.85M | 14.42 | 15.51% | 1.99% | 28.06% | 208.80% | |
| ― | $2.18B | 17.61 | 28.11% | 1.56% | 30.05% | 73.23% | |
| ― | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
| ― | $7.57B | -38.68 | -8.31% | ― | 6.27% | 93.14% |
Drdgold Corporate Events
On October 17, 2025, Riaan Davel, the Chief Financial Officer of DRDGOLD Limited, executed an on-market sale of 137,067 ordinary shares of the company. The sale, conducted at a volume-weighted average price of R54.599 per share, amounted to a total transaction value of R7,483,745.05. This transaction was carried out in compliance with the JSE Limited Listings Requirements, with prior clearance obtained.
DRDGOLD Limited reported a 2% increase in gold production to 1,191 kg for the quarter ended September 30, 2025, despite a 3% decrease in ore milled. The company benefited from a high average gold price of R1,943,398/kg, which contributed to a stable revenue of R2,254.9 million, a 2% increase from the previous quarter. Cash operating costs rose by 3% due to annual labor increases and higher reagent costs, while all-in sustaining costs increased due to higher cash operating costs and growth capital expenditure related to the Far West Gold Recoveries Phase II project. The company remains debt-free, although cash and cash equivalents decreased by R257.1 million after dividend payments and capital expenditures.
On September 26, 2025, DRDGOLD Limited announced that VanEck Associates Corporation has disposed of a beneficial interest in the company, reducing its holding to 1.46% of the total issued ordinary share capital. This disposal requires DRDGOLD to file notifications with the Takeover Regulation Panel and the Companies and Intellectual Property Commission, as per the Companies Act and JSE Listings Requirements.
On August 21, 2025, DRDGOLD Limited announced the acceptance of awards under its Single Incentive Plan, which includes the Deferred Share Plan. This plan, approved by shareholders in November 2023, grants deferred shares to qualifying employees annually. The awards vest over three to five years, depending on the employee’s band, and are settled in DRDGOLD ordinary shares at no exercise price. The announcement highlights the acceptance of awards by several directors and officers, indicating a significant commitment to employee retention and alignment with company performance. This strategic move is expected to strengthen DRDGOLD’s operational stability and enhance shareholder value.
DRDGOLD Limited announced its reviewed condensed consolidated financial statements for the year ended June 30, 2025, reporting a significant increase in financial performance compared to the previous year. The company achieved a 26% increase in revenue, a 69% rise in operating profit, and a 100% increase in the final cash dividend to 40 South African cents per share. Despite a 3% decrease in gold production, DRDGOLD maintained a strong financial position, supported by a robust gold price and strategic operational adjustments. The announcement also highlighted the company’s efforts to expand deposition capacity at its Ergo Mining operations, aiming to extend the operation’s life and improve environmental sustainability. These developments are expected to enhance DRDGOLD’s industry positioning and benefit stakeholders by increasing production capacity and reducing environmental impact.
On August 19, 2025, DRDGOLD Limited announced a change to its board committee due to Sibanye Stillwater Limited’s decision to retain Andrew Brady as a consultant for six months starting July 1, 2025. As a result, Brady has stepped down from the Audit Committee but will continue to serve on the Risk and Investment Committees. The company assures that the Audit Committee’s composition remains compliant with relevant governance and listing requirements.
DRDGOLD Limited has announced its trading statement for the year ended June 30, 2025, reporting a significant increase in earnings per share (EPS) and headline earnings per share (HEPS) by 64% to 74% compared to the previous year. This growth is attributed to a 31% increase in the Rand gold price received, despite a slight decrease in gold sold. The company also reported a 26% increase in group revenue and a 4% rise in cash operating costs. Notably, DRDGOLD achieved its production guidance with 155,288 ounces of gold produced and maintained strong liquidity with R1,306.2 million in cash and no bank debt as of June 30, 2025.